Appearance of Plasma Amino Acids Following Consumption of an Oral Nutrition Supplement

NCT ID: NCT02717234

Last Updated: 2023-05-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-02-29

Study Completion Date

2016-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess the effect of consumption of an oral nutrition supplement on Arginine, a blood marker of nutritional intake

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Subjects

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Impact Advanced Recovery

Oral nutrition supplement intended for consumption at 3 servings per day

Group Type ACTIVE_COMPARATOR

Oral Nutrition Supplement

Intervention Type OTHER

Oral nutrition supplement intended for consumption at 3 servings per day

Impact Advanced Recovery-R

Oral nutrition supplement intended for consumption at 3 servings per day

Group Type EXPERIMENTAL

Oral Nutrition Supplement

Intervention Type OTHER

Oral nutrition supplement intended for consumption at 3 servings per day

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oral Nutrition Supplement

Oral nutrition supplement intended for consumption at 3 servings per day

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy subject (absence of metabolic disorder, heart disease, endocrine disease, cancer)
* Discontinued use of omega 3 fatty acid supplements - 10 days prior to testing
* Willing to provide signed informed consent

Exclusion Criteria

* Smoker
* Patients with potential for non-compliance
* Patients with allergy to ingredients in test products (i.e. milk protein, fish oil)
* Subject who in the Investigator's assessment cannot be expected to comply with study protocol
* Currently participating in another conflicting clinical trial.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Société des Produits Nestlé (SPN)

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sherwyn Schwartz, MD

Role: PRINCIPAL_INVESTIGATOR

Diabetes & Glandular Disease Clinic, PA

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

14.31.US.CLI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Amino Acid Nutrition in the Critically-ill
NCT02865408 ACTIVE_NOT_RECRUITING NA